Vitamin D concentration and lateral cerebral ventricle volume in older adults

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 267-276

  Annweiler, Cédric ^a,b,c   Montero Odasso, Manuel ^b   Hachinski, Vladimir ^d   Seshadri, Sudha ^e   Bartha, Robert ^c   Beauchet, Olivier ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lateral cerebral ventricle; Neurodegeneration; Neuroendocrinology; Older adults; Vitamin D

Indexed keywords

VITAMIN D;

AGED; ARTICLE; BLOOD; BRAIN VENTRICLE; CALCIUM INTAKE; CAUCASIAN; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; STATISTICAL MODEL; VITAMIN D DEFICIENCY;

AGED; CALCIUM, DIETARY; CEREBRAL VENTRICLES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; MALE; VITAMIN D; VITAMIN D DEFICIENCY;

RODENTIA;

EID: 84872871532     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200418     Document Type: Article

References (60)

1. Holick, M. F., Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
2. Annweiler, C., Souberbielle, J.C., Schott, A.M., de Decker, L. et al., Vitamin D in the elderly: 5 points to remember. Geriatr. Psychol. Neuropsychiatr. Vieil. 2011, 9, 259-267.
3. Holmøy, T., Moen, S. T., Gundersen, T. A., Holick, M. F. et al., 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult. Scler. 2009, 15, 1280-1285.
4. Balabanova, S., Richter, H. P., Antoniadis, G., Homoki, J. et al., 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1, 25-dihydroxyvitamin D in human cerebrospinal fluid. Klin. Wochenschr. 1984, 62, 1086-1090.
5. Kalueff, A. V., Tuohimaa, P., Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10, 12-19.
6. Annweiler, C., Schott, A. M., Berrut, G., Chauviré, V. et al., Vitamin D and ageing: neurological issues. Neuropsychobiology 2010, 62, 139-150.
7. Dickens, A. P., Lang, I. A., Langa, K. M., Kos, K. et al., Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 2011, 25, 629-639.
8. Annweiler, C., Allali, G., Allain, P., Bridenbaugh, S. et al., Vitamin D and cognitive performance in adults: a systematic review. Eur. J. Neurol. 2009, 16, 1083-1089.
9. Etgen, T., Sander, D., Bickel, H., Sander, K. et al., Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 2012, 33, 297-305.
10. Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J. et al., Vitamin D3 and brain development. Neuroscience 2003, 118, 641-653.
11. Féron, F., Burne, T. H., Brown, J., Smith, E. et al., Developmental vitamin D3 deficiency alters the adult rat brain. Brain. Res. Bull. 2005, 65, 141-148.
12. Turner, B., Ramli, N., Blumhardt, L. D., Jaspan, T. Ventricular enlargment in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates. Neuroradiology 2001, 43, 608-614.
13. Annweiler, C., Montero-Odasso, M., Bartha, R., Beauchet, O., Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78, 1281-1282.
14. Annweiler, C., Fantino, B., Schott, A. M., Krolak-Salmon, P. et al., Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur. J. Neurol. 2012, 19, 1023-1029.
15. Thomas-Antérion, C., Ribas, C., Honoré-Masson, S., Million, J., Evaluation de la plainte cognitive de patients Alzheimer, de sujets MCI, anxiodépressifs et de témoins avec le QPC (Questionnaire de Plainte Cognitive). Neurol. Psychiatr. Geriatr. 2004, 20, 30-35.
16. Folstein, M. F., Folstein, S. E., McHugh, P. R., Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189-198.
17. Shprecher, D., Schwalb, J., Kurlan, R., Normal pressure hydrocephalus: diagnosis and treatment. Curr. Neurol. Neurosci. Rep. 2008, 8, 371-376.
18. Dubois, B., Sarazin, M., Lehericy, S., Chupin, M. et al., P2a-4 etude hippocampe : evaluation de l'efficacité du donépézil versus placebo sur des marqueurs IRM et cliniques chez des patients présentant des troubles cognitifs légers. Revue Neurologique 2009, 165, 66-67.
19. Accomazzi, V., Lazarowich, R., Barlow, C. J., Davey, B., Inventors; Cedara Software Corp, assignee. Image region segmentation system and method. US Patent Application 20050031202.2005 Feb 10.
20. Nestor, S. M., Rupsingh, R., Borrie, M., Smith, M. et al., Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging inititiative database. Brain 2008, 131, 2443-2454.
21. Carmichael, O. T., Kuller, L. H., Lopez, O. L., Thompson, P. M. et al., Ventricular volume and dementia progression in the cardiovascular health study. Neurobiol. Aging 2007, 28, 389-397.
22. Saha, P. K., Udupa, J. K., Odhner, D., Scale-based fuzzy connected image segmentation: theory, algorithms, and validation. CVIU 2000, 77, 145-174.
23. Carter, G. D., Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr. Drug. Targets 2011, 12, 19-28.
24. Lai, J. K., Lucas, R. M., Clements, M. S., Harrison, S. L. et al., Assessing vitamin D status: pitfalls for the unwary. Mol. Nutr. Food. Res. 2010, 54, 1062-1071.
25. World Health Organization, Prevention and Management of Osteoporosis: Report of a WHO Scientific Group, World Health Organization, Geneva 2003.
26. Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F. et al., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 2010, 96, 53-58.
27. Folstein, M. F., Folstein, S. E., McHugh, P. R., Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189-198.
28. Izzo, J. L. Jr., Sica, D. A., Black, H. R. (Eds.), Hypertension Primer: The Essentials of High Blood Pressure. Basic Science, Population Science, and Clinical Management. 4th ed., American Heart Association, Dallas 2008.
29. Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. et al., MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR. Am. J. Roentgenol. 1987, 149, 351-356.
30. Leaper, S. A., Murray, A. D., Lemmon, H. A., Staff, R. T. et al., Neuropsychologic correlates of brain white matter lesions depicted on MR images: 1921 Aberdeen Birth Cohort. Radiology 2001, 221, 51-55.
31. Rochon, J., Gondan, M., Kieser, M., To test or not to test: preliminary assessment of normality when comparing two independent samples. BMC Med. Res. Methodol. 2012, 12, 81.
32. Box, G. E. P., Non-normality and tests on variances. Biometrika 1953, 40, 318-335.
33. Annweiler, C., Fantino, B., Le Gall, D., Schott, A. M. et al., Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J. Am. Geriatr. Soc. 2011, 59, 169-171.
34. Buell, J.S., Dawson-Hughes, B., Scott, T.M., Weiner, D. E. et al., 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74, 18-26.
35. Annweiler, C., Rolland, Y., Schott, A.M., Blain, H. et al., Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement. Geriatr. Cogn. Disord. 2012, 32, 273-278.
36. Summerday, N. M., Brown, S. J., Allington, D. R., Rivey, M. P., Vitamin D and multiple sclerosis: review of possible association. J. Pharm. Pract. 2012, 25, 75-84.
37. McGrath, J.J., Eyles, D.W., Pedersen, C.B., Anderson, C. et al., Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch. Gen. Pshychiat. 2010, 67, 889-894.
38. Annweiler, C., Montero-Odasso, M., Muir, S. W., Beauchet, O.; WALK Team. Vitamin D and brain imaging in the elderly: should we expect some variation specifically related to hypovitaminosis D? Open Neuroimag. J. 2012, 6, 16-18.
39. Bowman, G. L., Silbert, L. C., Howieson, D., Dodge, H. H. et al., Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78, 241-249.
40. Chance, S. A., Esiri, M. M., Crow, T. J., Ventricular enlargement in schizophrenia: a primary change in the temporal lobe? Schizophr. Res. 2003, 62, 123-131.
41. Fletcher, P. C., Frith, C. D., Rugg, M. D., The functional neuroanatomy of episodic memory. Trends Neurosci. 1997, 20, 213-218.
42. Buell, J. S., Scott, T. M., Dawson-Hughes, B., Dallal, G. E. et al., Vitamin D is associated with cognitive function in elders receiving home health services. J. Gerontol. A. Biol. Sci. Med. Sci. 2009, 64, 888-895.
43. Lee, D. M., Tajar, A., Ulubaev, A., Pendleton, N. et al., Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J. Neurol. Neurosurg. Psychiat. 2009, 80, 722-729.
44. Lichter, D. G., Cummings, J. L. (Eds.). Frontal-Subcortical Circuits in Psychiatric, and Neurological Disorders, Guilford Press, New York 2001.
45. Llewellyn, D. J., Lang, I. A., Langa, K. M., Muniz-Terrera, G. et al., Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 2010, 170, 1135-1141.
46. Saporito, M. S., Wilcox, H. M., Hartpence, K. C., Lewis, M. E. et al., Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol. 1993, 123, 295-302.
47. Brown, J., Bianco, J. I., McGrath, J. J., Eyles, D. W., 1, 25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosus in embryonic rat. Neurosci. Lett. 2003, 343, 139-143.
48. Gezen-Ak, D., Dursun, E., Yilmaze, S., The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-AD1D and the release of NGF in cortical neurons. PloS One 2011, 6, e17553.
49. Ho, R., Ortiz, D., Shea, T. B., Amyloid-beta promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons. J. Alzheimers Dis. 2011, 3, 479-483.
50. Masoumi, A., Goldenson, B., Ghirmai, S., Avaqyan, H. et al., 1alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 2009, 17, 703-717.
51. Mizwicki, M. T., Menegaz, D., Zhang, J., Barrientos-Durán, A. et al., Genomic and nongenomic signaling induced by 1α, 25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. J. Alzheimers Dis. 2012, 29, 51-62.
52. Ito, S., Ohtsuki, S., Nezu, Y., Koitabashi, Y. et al., 1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-b peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS. 2011, 8, 20.
53. Dursun, E., Gezen-Ak, D., Yilmaze, S., A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β induced alterations by vitamin D in cortical neurons. J. Alzheimers Dis. 2011, 23, 207-219.
54. Schram, M. T., Trompet, S., Kamper, A. M., de Craen, A. J. et al., Serum calcium and cognitive function in old age. J. Am. Geriatr. Soc., 2007, 55, 1786-1792.
55. Harrison, P. J., The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 1999, 122, 593-624.
56. Carmichael, O. T., Kuller, L. H., Lopez, O. L., Thompson, P. M. et al., Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol. Aging 2007, 28, 389-397.
57. Smith, C. D., Snowdon, D., Markesbery, W. R., Periventricular white matter hyperintensities on MRI: correlation with neuropathological findings. J. Neuroimaging 2000, 10, 13-16.
58. Schott, J. M., Price, S. L., Frost, C., Whitwell, J. L. et al., Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology 2005, 65, 119-124.
59. Ridha, B. H., Anderson, V. M., Barnes, J., Boyes, R. G. et al., Volumetric MRI and cognitive measures in Alzheimer disease. J Neurol. 2008, 255, 567-574.
60. Heaney, R. P., Vitamin D in health and disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1535-1541.